Corporate Social Responsability
Our 2021 Corporate Social Responsibility report
This report formalizes our commitment to a sustainable and ethical approach of our practices in order to meet social and environmental challenges. SGH Medical Pharma’ strategy is based on shared values that are essential to the completion of our daily tasks.
This report illustrates the main actions carried our during the year 2021.
A word from our CEO
« SGH Medical Pharma’s commitment is at a turning point. To reach a high level of coherence between our customers’ and our stakeholders’ expectations, we have made ambitious commitments for the future. Every day, our teams ensure that they are met by building upon their skills and know-how in harmony with the values of the group. »
Jérôme Empereur
CEO SGH Medical Pharma
Our commitments
Our approach revolves around 4 main axes:
Making a positive contribution to society
Reducing our impact on the environment
Taking care of our stakeholders
Provide sustainable employment
Making a positive contribution to society
8%
of employees are in apprenticeship contracts
90%
of suppliers in France
100%
of suppliers have signed our Code of Ethics according to our objectives
98%
of suppliers in Europe
Reducing our impact on the environment
35
new materials tried out
Energy performance indicators :
163t
of recycled plastics
2mWh
consumed per ton of material used
70t
of recycled cardboard
+54%
increase in electric presses
1t
of recycled office waste
557t
of CO2 released thanks to our waste management
Taking care of our stakeholders
Tracking
well-being at work
93%
hiring rate for permanent employees
Ensuring employee’s health and safety
7/10
average well being at work grade
Building a trust relationship with our stakeholders: 1 yearly check
2327h
dedicated to training
Provide sustainable employment
69%
of employees trained each year
100%
of employees CSR-conscious
Innovate through
Life Cycle Assessment
100%
of employees trained through the last 3 years
Our acknowledgments
Lucie 26000
Our CSR approach, carried out at the highest level of the company, is established for the whole group but is also supported by all employees. This demonstrates the organization’s willingness to integrate social and environmental considerations into its decision-making processes and to be accountable for the impact of its decisions and activities on society and the environment. These actions have been externally audited, which led to the LUCIE 26000 certification.
Ecovadis
We are regularly assessed by ECOVADIS, an internationally recognized company, to evaluate our sustainable development performance across the entire company based on 7 CSR criteria. In 2022, we obtained the gold medal in the Medium Size Company category, with a score of 74/100.
ISO 14001 : 2015 certification
Two sites are certified ISO 14001.
Certificates of conformity to decree n°2021-461 from April 1, 2021
As part of the AGEC law for anti-waste and circular economy and to comply with decree n°2021-461, our manufaturing sites have been audited in order to assess the measures taken to prevent the loss and discharge of industrial plastic compounds into the environment. This approach underlines our commitment to reducing our impact on the environment.
Find our certificates for the Stiplastics, Rovipharm and Eskiss sites (French only).
Our support
SGH Medical Pharma attaches great importance to respecting the laws, regulations and universal ethical principles supported by the Universal Declaration of Human Rights and as described in the 17 UN Sustainable Development Goals, for all our activities around the world. Therefore, we naturally renewed our support to UN Global Compact, as we have done since 2009.
